SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver

  • Diagnostics guidance
  • DG5
  • Published: 

History

Documents created during the development process.

Review consultation

SonoVue (sulphur hexafluoride microbubbles) - contrast agent for contrast enhanced ultrasound in liver imaging: equality impact assessment

SonoVue (sulphur hexafluoride microbubbles) - contrast agent for contrast enhanced ultrasound in liver imaging: public consultation comments

SonoVue (sulphur hexafluoride microbubbles): committee meeting confirmed minutes - 6 June 2012

SonoVue (sulphur hexaflouride microbubbles): diagnostics consultation

SonoVue overview

SonoVue diagnostic assessment report

SonoVue (sulphur hexafluoride microbubbles): DAR comments and external assessment group responses

SonoVue (sulphur hexafluoride microbubbles): committee meeting confirmed minutes - 03 April 2012

SonoVue (sulphur hexafluoride microbubbles): diagnostics advisory committee - information for applicants

SonoVue (sulphur hexafluoride microbubbles): scope

SonoVue (sulphur hexafluoride microbubbles): protocol

SonoVue (sulphur hexafluoride microbubbles): topic description